Abstract
Airway remodeling and associated angiogenesis are documented features of asthma, of which the molecular mechanisms are not fully understood. Angiotensin (ANG)II and endothelin (ET)-1 are potent vasoconstricting circulatory hormones implicated in asthma. We investigated the effects of ANG II and ET-1 on human airway smooth muscle (ASM) cells proliferation and growth and examined the mRNA expression and release of the angiogenic peptide, vascular endothelial growth factor (VEGF). Serum deprived (48 h) human ASM cells were incubated with ANG II (100 nM) or ET-1 (10nM) for 30 min, 1, 2, 4, 8, 16, and 24 h and the endogenous synthesis of VEGF was examined in relation to control cells receiving serum free culture medium. ET-1 induced time dependent DNA biosynthesis as determined by [3H]-thymidine incorporation assay. Using northern blot hybridization, we detected two mRNA species of 3.9 and 1.7 kb encoding VEGF in the cultured smooth muscle cells. Both ANG II and ET-1 induced the mRNA expression (two-to threefold) and secretion (1.8-to 2.8-fold) of VEGF reaching maximal levels between 4–8 h of incubation. Induced expression and release of VEGF declined after 8 h of ANG II incubation while levels remained elevated in the case of ET-1. The conditioned medium derived from ET-1-treated ASM cells induced [3H]-thymidine incorporation and cell number in porcine pulmonary artery endothelial as well as human umbilical vein endothelial cells. Moreover, the VEGF tyrosine kinase receptor inhibitor blocked the conditioned medium induced mitogenesis in endothelial cells. Our results suggest a potential role for ANG II and ET-1 in ASM cell growth and upregulation of VEGF that may participate in endothelial cell proliferation via paracrine mechanisms and thus causing pathological angiogenesis and vascular remodelling seen during asthma.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
References
Lazaar, A. L. and Panettieri, R. A., Jr. (2005) Airway smooth muscle: a modulator of airway remodeling in asthma. J. Allergy Clin. Immunol. 116, 488–495.
Kranenburg, A. R., de Boer, W. L., Alagappan, V. K., Sterk, P. J., and Sharma, H. S. (2005) Enhanced bronchial expression of vascular endothelial growth factor and receptors (Flk-1 and Flt-1) in patients with chronic obstructive pulmonary disease. Thorax 60, 106–113.
Kranenburg, A. R., De Boer, W. I., Van Krieken, J. H., et al (2002) Enhanced expression of fibroblast growth factors and receptor FGFR-1 during vascular remodeling in chronic obstructive pulmonary disease. Am. J. Respir. Cell. Mol. Biol. 27, 517–525.
McDonald, D. M. (2001) Angiogenesis and remodeling of airway vasculature in chronic inflammation. Am. J. Respir. Cirt. Care Med. 164, S39-S45.
Wilson, J. (2000) The bronchial microcirculation in asthma. Clin. Exp. Allergy 30 (Suppl. 1), 51–53.
Burgess, J. K., Ge, Q., Poniris, M. H., et al. (2006) Connective tissue growth factor and vascular endothelial growth factor from airway smooth muscle interact with the extracellular matrix. Am. J. Physiol. Lung Cell. Mol. Physiol. 290, L153-L161.
Bousquet, J., Jeffery, P. K., Busse, W. W., Johnson, M., and Vignola, A. M. (2000). Asthma. From bronchoconstriction to airways inflammation and remodeling. Am. J. Respir. Crit. Care Med. 161, 1720–1745.
Chiappara, G., Gagliardo, R., Siena, A., et al. (2001) Airway remodelling in the pathogenesis of asthma. Curr. Opin. Allergy Clin. Immunol. 1, 85–93.
Knox, A. J., Corbett, L., Stocks, J., Holland, E., Zhu, Y. M. and Pang, L. (2001) Human airway smooth muscle cells secrete vascular endothelial growth factor: up-regulation by bradykinin via a protein kinase C and prostanoiddependent mechanism. FASEB J. 15, 2480–2488.
Salvato, G. (2001) Quantitative and morphological analysis of the vascular bed in bronchial biopsy specimens from asthmatic and non-asthmatic subjects. Thorax 56, 902–906.
Santos, S., Peinado, V. I., Ramirez, J. et al. (2003) Enhanced expression of vascular endothelial growth factor in pulmonary arteries of smokers and patients with moderate chronic obstructive pulmonary disease. Am. J. Respir. Crit. Care Med. 167, 1250–1256.
Hoshino, M., Nakamura, Y., and Hamid, Q. A. (2001) Gene expression of vascular endothelial growth factor and its receptors and angiogenesis in bronchial asthma. J. Allergy Clin. Immunol. 107, 1034–1038.
Rumpold, H., Wolf, D., Koeck, R., and Gunsilius, E. (2004) Endothelial progenitor cells: a source for therapeutic vasculogenesis? J. Cell. Mol. Med. 8, 509–518.
Voelkel, N. F., Vandivier, R. W., and Tuder, R. M. (2006) Vascular endothelial growth factor in the lung. Am. J. Physiol. Lung Cell. Mol. Physiol. 290, L209-L221.
Carmeliet, P. (2005) Angiogenesis in life, disease and medicine. Nature 438, 932–936.
Ferrara, N. (2005) The role of VEGF in the regulation of physiological and pathological angiogenesis. EXS 94, 209–231.
Imhof, B. A. and Aurrand-Lions, M. (2006) Angiogenesis and inflammation face off. Nat. Med 12, 171–172.
Alagappan, V. K., McKay, S., Widyastuti, A., et al. (2005) Proinflammatory cytokines upregulate mRNA expression and secretion of vascular endothelial growth factor in cultured human airway smooth muscle cells. Cell. Biochem. Biophys. 43, 119–130.
Shehata, S. M., Mooi, W. J., Okazaki, T., El-Banna, I., Sharma, H. S., and Tibboel, D. (1999) Enhanced expression of vascular endothelial growth factor in lungs of newborn infants with congenital diaphragmatic hernia and pulmonary hypertension. Thorax 54, 427–431.
Myou, S., Fujimura, M., Kamio, Y., et al. (2002) Effect of candesartan, a type 1 angiotensin II receptor antagonist, on bronchial hyper-responsiveness to methacholine in patients with bronchial asthma. Br. J. Clin. Pharmacol. 54, 622–626.
Spiropoulos, K., Trakada, G., Nikolaou, E., et al. (2003) Endothelin-1 levels in the pathophysiology of chronic obstructive pulmonary disease and bronchial asthma. Respir. Med. 97, 983–989.
Trakada, G., Tsourapis, S., Marangos, M., and Spiropoulos, K. (2000) Arterial and bronchoalveolar lavage fluid endothelin-1 concentration in asthma. Respir. Med. 94, 992–996.
Millar, E. A., Nally, J. E., and Thomson, N. C. (1995) Angiotensin II potentiates methacholine-induced bronchoconstriction in human airway both in vitro and in vivo. Eur. Respir. J. 8, 1838–1841.
Yanagisawa, M., Kurihara, H., Kimura, S., et al. (1988) A novel potent vasoconstrictor peptide produced by vascular endothelial cells. Nature 332, 411–415.
Chua, C. C., Hamdy, R. C., and Chua, B. H. (1998) Upregulation of vascular endothelial growth factor by angiotensin II in rat heart endothelial cells. Biochim. Biophys. Acta 1401, 187–194.
McKay, S., de Jongste, J. C., Saxena, P. R., and Sharma, H. S. (1998) Angiotensin II induces hypertrophy of human airway smooth muscle cells: expression of transcription factors and transforming growth factor-betal. Am. J. Respir. Cell. Mol. Biol. 18, 823–833.
Kizawa, Y., Ohuchi, N., Saito, K., Kusama, T., and Murakami, H. (2001) Effects of endothelin-1 and nitric oxide on proliferation of cultured guinea pig bronchial smooth muscle cells. Comp. Biochem. Physiol. C Toxicol. Pharmacol. 128, 495–501.
McKay, S., Hirst, S. J., Haas, M. B., et al. (2000) Tumor necrosis factor-alpha enhances mRNA expression and secretion of interleukin-6 in cultured human airway smooth muscle cells. Am. J. Respir. Cell. Mol. Biol. 23, 103–111.
Panettieri, R. A., Jr., Goldie, R. G., Rigby, P. J., Eszterhas, A. J., and Hay, D. W. (1996) Endothelin-1-induced potentiation of human airway smooth muscle proliferation: an ETA receptor-mediated phenomenon. Br. J. Pharmacol. 118, 191–197.
Seynhaeve, A. L., Vermeulen, C. E., Eggermont, A. M., and ten Hagen, T. L. (2006) Cytokines and vascular permeability: an in vitro study on human endothelial cells in relation to tumor necrosis factor-alpha-primed peripheral blood mononuclear cells. Cell Biochem. Biophys. 44, 157–169.
James, A. L., Pare, P. D., and Hogg, J. C. (1989) The mechanics of airway narrowing in asthma. Am. Rev. Respir. Dis. 139, 242–246.
Hirst, S. J., Martin, J. G., Bonacci, J. V., et al., (2004) Proliferative aspects of airway smooth muscle. J. Allergy Clin. Immunol. 114, S2-S17.
Parameswaran, K., Willems-Widyastuti, A., Alagappan, V. K. Radford, K., Kranenburg, A. R., and Sharma, H. S. (2006) Role of extracellular matrix and its regulators in human airway smooth muscle biology. Cell Biochem. Biophys. 44, 139–146.
Stocks, J., Bradbury, D., Corbett, L., Pang, L., and Knox, A. J. (2005) Cytokines upregulate vascular endothelial growth factor secretion by human airway smooth muscle cells: role of endogenous prostanoids. FEBS Lett. 579, 2551–2556.
Asai, K., Kanazawa, H., Kamoi, H., Shiraishi, S., Hirata, K., and Yoshikawa, J. (2003) Increased levels of vascular endothelial growth factor in induced sputum in asthmatic patients. Clin. Exp. Allergy 33, 595–599.
Lee, Y. C., Kwak, Y. G., and Song, C. H. (2002) Contribution of vascular endothelial growth factor to airway hyperresponsiveness and inflammation in a murine model of toluene diisocyanate-induced asthma. J. Immunol. 168, 3595–3600.
Pertovaara, L., Kaipainen, A., Mustonen, T., et al. (1994) Vascular endothelial growth factor is induced in response to transforming growth factor-beta in fibroblastic and epithelial cells. J. Biol. Chem. 269, 6271–6274.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
Open Access This is an open access article distributed under the terms of the Creative Commons Attribution Noncommercial License ( https://creativecommons.org/licenses/by-nc/2.0 ), which permits any noncommercial use, distribution, and reproduction in any medium, provided the original author(s) and source are credited.
About this article
Cite this article
Alagappan, V.K.T., Willems-Widyastuti, A., Seynhaeve, A.L.B. et al. Vasoactive peptides upregulate mRNA expression and secretion of vascular endothelial growth factor in human airway smooth muscle cells. Cell Biochem Biophys 47, 109–118 (2007). https://doi.org/10.1385/CBB:47:1:109
Issue Date:
DOI: https://doi.org/10.1385/CBB:47:1:109